Tolerance induction by CD40 silenced dendritic cells through antisense

Iranian Red Crescent Medical Journal

Volumn 11, Issue 3, 2009, Pages 286-294

  Karimi, M H ^a,e   Ebadi, P ^b   Pourfathollah, Ali Akbar ^a   Soheili, Z S ^c   Samiee, S H ^d   Ataee, Z ^d   Tabei, S Z ^e   Nadali, F ^f   Moazeni, S M ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c Institute of Genetic Engineering and Biotechnology   (Iran)

^d IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antisense; CD40; Dendritic cell; Tolerance induction

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CD40 ANTIGEN; INTERLEUKIN 4; LIPOCORTIN 5; LIPOFECTAMINE; MESSENGER RNA; PROPIDIUM IODIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LIPOSOMAL GENE DELIVERY SYSTEM; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; TH2 CELL;

EID: 67749102226     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811. [1083 7075] [doi:10.1146 /annurev.immunol.18.1.767]
2. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96. [1910679] [doi:10.1146/ annurev.iy.09.040191.001415]
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52. [9521319] [doi:10.1038/32588]
4. Hackstein H, Thomson AW. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 2004; 4:24-34. [14704765] [doi:10.1038/nri1256]
5. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007;7:610-21. [17627284] [doi:10.1038/nri2132]
6. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007;449:419-26. [17898760] [doi: 10.1038 /nature06175]
7. Stax AM, Crul C, Kamerling SW, Schlagwein N, van der Geest RN, Woltman AM, van Kooten C. CD40L stimulation of rat dendritic cells specifically favors the IL-12/IL-10 ratio resulting in a strong T cell stimulatory capacity. Mol Immunol 2008; 45:2641-50. [18262271] [doi:10.1016/j.molimm.2007.12.014]
8. Van Kooten C, Bancheraeu J. CD40-CD40 ligand. J Leukoc Biol 2000;67:2-17. [10647992]
9. Schönbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001;58:4-43. [11 229815] [doi:10.1007 /PL00000776]
10. Castigli E, Alt FW, Davidson L, Bottaro A, Mizoguchi E, Bhan AK, Geha RS. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci USA 1994; 91:12135-9. [7527552] [doi:10.1073/pnas.91.25.12135]
11. Kurreck J. Antisense technologies. Improvement through novel chemical modifications. Eur J Biochem 2003; 270:1628-44. [12694176] [doi:10.1046/j.1432-1033.2003.03555.x]
12. Tamm I, Dörken B, Hartmann G. Antisense therapy in oncology: new hope for an old idea? Lancet 2001;358:489-97. [11513935] [doi: 10.1016/S0140-6736(01)05629-X]
13. Zarnani AH, Moazzeni SM, Shokri F, Salehnia M, Dokouhaki P, Shojaeian J, Jeddi-Tehrani M. The efficient isolation of murine splenic dendritic cells and their cytochemical features. Histochem Cell Biol 2006; 126:275-82. [16607536] [doi: 10.1007/s00418-006-0181-6]
14. Siwkowski AM, Malik L, Esau CC, Maier MA, Wancewicz EV, Albertshofer K, Monia BP, Bennett CF, Eldrup AB. Identification and functional validation of PNAs that inhibit murine CD40 expression by redirection of splicing. Nucleic Acids Res 2004;32:2695-706. [15148357] [doi:10.1093/nar/gkh584]
15. Min WP, Gorczynski R, Huang XY, Kushida M, Kim P, Obataki M, Lei J, Suri RM, Cattral MS. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. J Immunol 2000; 164:161-7. [10605007]
16. Ebadi P, Karimi MH, Pourfathollah AA, Saheb Ghadam Lotfi A, Soheili ZS, Samiee S, Hajati S, Nadali F, Geramizadeh B, Moazzeni SM. The Efficiency of CD40 Down Regulation by siRNA and Antisense ODN: Comparison of Lipofectamine and FuGENE6. Iran J Immunol 2009; 6:1-11. [19293472]
17. Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 1998; 70:83-243. [9755338] [doi:10.1016/S0065-2776(08)60387-9]
18. Lu L, Rudert WA, Qian S, McCaslin D, Fu F, Rao AS, Trucco M, Fung JJ, Starzl TE, Thomson AW. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med 1995;182:379-87. [7629500] [doi:10.1084/jem.182.2.379]
19. Fu F, Li Y, Qian S, Lu L, Chambers F, Starzl TE, Fung JJ, Thomson AW. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62:659-65. [8830833] [doi:10.1097/00007890-199609150-00021]
20. Sun W, Wang Q, Zhang L, Liu Y, Zhang M, Wang C, Wang J, Cao X. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin. Transplantation 2003;76: 1351-9. [14627915] [doi:10.1097/01.TP.0000083557.25887.EE]
21. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002;23:445-9. [12200066] [doi:10.1016/S1471-4906(02)02281-0]
22. Prechtel AT, Turza NM, Theodoridis AA, Steinkasserer A. CD83 knockdown in monocyte-derived dendritic Cells by small interfering RNA leads to a diminished T Cell stimulation. J Immunol 2007;178:5454-64. [174 42926]
23. Machen J, Harnaha J, Lakomy R, Styche A, Trucco M, Giannoukakis N. Antisense oligonucleotides down-regulating co stimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells. J Immunol 2004;173:4331-41. [15383562]
24. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711. [12615891] [doi:10.1146/ annurev.immunol.21.120601.141040]
25. Quezada S, Jarvinen LZ, Lind EF, Noelle RJ. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 2004; 22:307-28. [15032580] [doi:10.1146 /annurev.immunol.22.012703.104533]
26. Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for co stimulation and inhibition of immune responses. Annu Rev Immunol 2002;20:29-53. [11861596] [doi:10.1146/ annurev.immunol.20.091101.091806]
27. Von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005;6:338-44. [157 85759] [doi:10.1038/ni1180]
28. Akhtar S, Hughes MD, Khan A, Bibby M, Hussain M, Nawaz Q, Double J, Sayyed P. The delivery of antisense therapeutics. Adv Drug Deliv Rev 2000;44:3-21. [11035194] [doi:10.1016 /S0169-409X(00)00080-6]
29. Kohka H, Iwagaki H, Yoshino T, Kobashi K, Urushihara N, Yagi T, Tanimoto T, Kurimoto M, Akagi T, Tanaka N. Involvement of interleukin-18 (IL-18) in mixed lymphocyte reactions (MLR). J Interferon Cytokine Res 1999;19:1053-7. [10505749] [doi:10.1089/107999099313280]
30. Tadmori W, Zhang M, Beavis AJ, Sullivan LM, Narula SK. Suppression of the allogeneic response by human IL-10: a critical role for suppression of a synergy between IL-2 and TNF-α. Cytokine 1994; 6:462-71. [7827283] [doi:10.1016/1043-4666(94)90072-8]
31. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/ IL-12 synthesis in accessory cells. J Exp Med 1993; 178:1041-8. [8102388] [doi:10.1084/jem.178.3.1041]
32. Gao JX, Madrenas J, Zeng W, Cameron M J, Zhang Z, Wang J J, Zhong R, Grant D. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection. Immunology 1999; 98:159-70. [10540 214] [doi:10.1046/j.1365-2567.1999.00863.x]
33. Kapsenberg ML. Dendritic cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003; 3:984-93. [14647480] [doi:10.1038/nri1246]
34. Caux C, Massacrier C, Vanbervliet B, Barthelemy C, Liu YJ, Banchereau J. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int Immunol 1994;6:1177-85. [7526890] [doi:10.1093/ intimm/6.8.1177]
35. Liang X, Lu L, Zhang H, Vickers T, Fung JJ, Qian S. Phenotype and allostimulatory function of dendritic cell treated with antisense oligodeoxynucleotides targeting CD80 or CD86 mRNA. Transplant Proc 2001; 33:235. [11266796] [doi:10.1016/S0041-1345(00)01991-6]
36. Cong Y, Weaver CT, Lazenby A, Elson CO. Colitis induced by enteric bacterial antigen-specific CD4 T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12. J Immunol 2000;165:2173-82. [10925304]
37. Liang X, Lu L, Chen Z, Vickers T, Zhang H, Fung JJ, Qian S. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation 2003;76:721-9. [12973117] [doi:10.1097/01.TP.0000076470.35404.49]
38. Gao D, Wagner A H, Fankhaenel S, Stojanovic T, Schweyer S, Panzner S, Hecker M. CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis. Gut 2005;54:70-7. [15591 506] [doi:10.1136/gut.2003.029587]
39. Giannoukakis N, Bonham CA, Qian S, Chen Z, Peng L, Harnaha J, Li W, Thomson AW, Fung JJ, Robbins PD, Lu L. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol Ther 2000; 1:430-7. [10933964] [doi:10.1006/mthe.2000.0060]